Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02555410 · ClinicalTrials.gov registry record
Seizure Detection and Warning System in Epilepsy Patients
A clinical trial of Epilepsy and Generalized Tonic-Clonic Seizures, sponsored by Brain Sentinel.
- Completed
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT02555410: Completed study of Epilepsy and Generalized Tonic-Clonic Seizures, sponsored by Brain Sentinel.
NCT02555410 is a study of Epilepsy and Generalized Tonic-Clonic Seizures that has completed, run by Brain Sentinel. The registered enrollment target is 11 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02555410, a study of Epilepsy and Generalized Tonic-Clonic Seizures, has completed, sponsored by Brain Sentinel.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a phase III, pilot, prospective study of an Electromyography (EMG) based seizure detection system for detecting Generalized Tonic-Clonic Seizures (GTCS) in the home.
Primary Outcome
The overall usability and technical features will be assessed through questionnaires and surveys as the Seizure Detection and Warning System will be used within a home setting.
Conditions Studied
Interventions
- DEVICE Brain Sentinel Seizure Detection and Warning System
Study Locations (1)
Texas
- Jose' E. Cavazos - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2013-01 |
| Est. Completion | 2017-07-07 |
What the finished NCT02555410 record still lists
NCT02555410 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Brain Sentinel Seizure Detection and Warning System is the first listed.
NCT02555410 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02555410 about?
NCT02555410 is a clinical study titled "Seizure Detection and Warning System in Epilepsy Patients". This is a phase III, pilot, prospective study of an Electromyography (EMG) based seizure detection system for detecting Generalized Tonic-Clonic Seizures (GTCS) in the home.
What is the current status of trial NCT02555410?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2013-01. Estimated completion is 2017-07-07.
What conditions does trial NCT02555410 study?
This clinical trial studies the following conditions: Epilepsy, Generalized Tonic-Clonic Seizures.
What interventions are being tested in trial NCT02555410?
The interventions under investigation include: Brain Sentinel Seizure Detection and Warning System (DEVICE).
Who is sponsoring clinical trial NCT02555410?
This trial is sponsored by Brain Sentinel, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02555410 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02555410's enrollment target sits among peer trials
11 146th of 160 higher than 14 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia